Given Imaging Guides Ingestible Microcapsule Through De Novo Process
This article was originally published in The Gray Sheet
Executive Summary
Given Imaging hopes to be the second company to have a product cleared by way of FDA's de novo program this year by proposing to include several cautionary statements in the labeling of its wireless endoscopy diagnostic imaging system.